Insmed Inc. sell klostergang
Start price
05.09.17
/
50%
€23.52
Target price
29.12.17
€16.24
Performance (%)
20.60%
End price
29.12.17
€28.36
Summary
This prediction ended on 29.12.17 with a price of €28.36. The SELL prediction by klostergang finished with a performance of 20.60%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Insmed Inc. | -10.909% | -10.909% | 121.053% | 703.279% |
| iShares Core DAX® | 0.765% | 4.791% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 1.418% | 3.133% | 5.422% | 113.046% |
| iShares Nikkei 225® | 0.658% | 0.972% | 15.333% | 47.267% |
| iShares S&P 500 | 1.310% | 2.279% | 3.125% | 68.687% |
Comments by klostergang for this prediction
In the thread Insmed Inc. diskutieren
klostergang stimmt der Sell-Einschätzung von kyron7htx zu
The open-label design of the Phase 3 trial will likely have a negative impact on secondary outcomes and may hinder the robustness of Insmed's NDA.
(Vom Mitglied beendet)